Interní Med. 2011; 13(4): 163-166

Patient with adrenocortical insufficiency in internist’s office

prof.MUDr.Michal Kršek, CSc.
3. interní klinika –, klinika endokrinologie a metabolizmu, 1. LF UK a VFN v Praze

Adrenocortical insufficiency (AI) is a condition characterized by decreased secretion of steroid hormones from adrenal cortex. Primary

AI is characterised by deficiency of all adrenocortical steroids, secondary AI is characterised mainly by deficiency of glucocorticoids

while secretion of mineralocorticoids is mostly preserved. Clinical presentation of chronic AI consists mainly of non-specific signs as

tiredness and weakness, however is can progress to more severe forms with hypotension, tachycardia, abdominal pain, hypoglycaemia,

hyperkalemia, acidosis and even circulatory failure with a threat of death. Therefore, there is a need for early and precise diagnosis and

proper treatment of AI. The secretion of glucocorticoids could be roughly estimated by assessment of basal serum levels of cortisol.

However, the use of dynamic testing of hypothalamic-pituitary-adrenal axis is indicated under certain circumstances. The treatment of

chronic AI consists of hormonal replacement therapy with glucocorticoids with a need for an increase in dose during stress situations. The

acute AI needs to be treated with high doses of glucocorticoids given parenteraly. In most cases with primary AI also mineralocorticoid

replacement usually in fixed dose is indicated.

Keywords: adrenal cortex, insufficiency, hypocorticism, Addison disease, diagnosis, treatment

Published: April 13, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kršek M. Patient with adrenocortical insufficiency in internist’s office. Interní Med. 2011;13(4):163-166.
Download citation

References

  1. Carrey RM. The changing clinical spectrum of adrenal insufficiency. Ann Intern Med 1997; 127: 1103-1105. Go to original source... Go to PubMed...
  2. Arlt W, Allolio B. Adrenal insufficiency. Lancet 2003; 361: 1881-1893. Go to original source... Go to PubMed...
  3. Loriaux DL, McDonald WJ. Adrenal insufficiency. In: De Groot LJ, Jameson, JL. (Eds). Endocrinology. 4th ed., W. B. Saunders, Philadelphia, Pennsylvania, USA 2001: 1685.
  4. Oelkers W. Adrenal insufficiency. N Engl J Med 1996; 335: 1206-1212. Go to original source... Go to PubMed...
  5. Artavia-Loria E, Chaussain JL, Bougneres PF, Job JC. Frequency of hypoglycaemia in children with adrenal insufficiency. Acta Endocrinol Suppl (Copenh.) 1986; 279: 275-278. Go to original source... Go to PubMed...
  6. Laczi F, Janaky T, Ivanyi T, et al. Osmoregulation and arginine-8-vasopressin secretion in primary hypothyroidism and in Addison's disease. Acta Endocrinol (Copenh.) 1987; 114: 389-395. Go to original source... Go to PubMed...
  7. Muls E, Bouillon R, Boelaert J, et al. Etiology of hypercalcemia in a patient with Addison disease. Calcif tissue Int 1982; 34: 523-526. Go to original source... Go to PubMed...
  8. Stewart PM. Glucocorticoid deficiency. In: Kronenberg HM, Melmed S, Polonsky KS, Reed Larsen P. (Eds). Williams Textbook of Endocrinology. 11th Edition, Saunders Elsevier, Philadelphia, Pennsylvania, USA 2008: 477-485.
  9. Hagg E, Asplund K, Lithner F. Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency. Clin Endocrinol (Oxf.) 1987; 26: 221-226. Go to original source... Go to PubMed...
  10. Ertuck E, Jaffe CA, Barkan AL. Evaluation of the integrity of the hypothalamo-pituitary adrenal axis by insulin hypoglycaemia test. J Clin Endocrinol Metab 1998; 83: 2350-2354. Go to original source...
  11. Stewart PM, Corrie J, Seckl JR, et al. A rational approach for assessing the hypothalamo-pituitary-adrenal axis. Lancet 1988; 1: 1208-1210. Go to original source... Go to PubMed...
  12. Clark PM, Neylon I, Raggatt PR, et al. Defining the normal cortisol response to the short synacthen test: Implications for the investigation of hypothalamic-pituitary disorders. Clin Endocrinol 1998; 49: 287-292. Go to original source... Go to PubMed...
  13. Lindholm J, Kehlet H. Re-evaluation of the clinical value of the 30 min ACTH test in assessing the hypothalamic-pituitary-adrenocortical function. Clin Endocrinol (Oxf.) 1987; 26: 53-69. Go to original source... Go to PubMed...
  14. Howlett TA. An assessment of optimal hydrocortisone replacement therapy. Clin Endocrinol 1997; 46: 263-268. Go to original source... Go to PubMed...
  15. Peacy SR. Glucocorticoid replacement therapy: are patients overtreated and does it matter? Clin Endocrinol 1997; 46: 255-261. Go to original source... Go to PubMed...
  16. Kršek M. Endokrinologie. In: Češka, R. Interna. Praha: Triton 2010: 318-371.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.